TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial.

L Ek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.